West Pharmaceutical Services, Inc. Website

West Pharmaceutical Services, Inc.

NYSE-WST

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

1,839.9

2,146.9

2,831.6

2,886.9

2,949.8

2,876.9

Total Revenues % Chg.

7.1%

16.7%

31.9%

2%

2.2%

0.4%

Cost of Goods Sold, Total

1,234.2

1,379.1

1,653.9

1,750.7

1,819.8

1,850.3

Gross Profit

605.7

767.8

1,177.7

1,136.2

1,130

1,026.6

Selling General & Admin Expenses, Total

272.8

300.8

356.3

316

354.1

349.4

Stock-Based Compensation

—

—

—

—

—

—

—

—

—

—

R&D Expenses

38.9

46.9

52.8

58.5

68.4

69.9

Other Operating Expenses

-2

-2.5

-4.3

-5.6

-3

-3.4

Other Operating Expenses, Total

309.7

345.2

404.8

368.9

419.5

415.9

Operating Income

296

422.6

772.9

767.3

710.5

610.7

Interest Expense, Total

-8.5

-8.2

-8.2

-7.9

-9

-7.2

Interest And Investment Income

3.8

1.4

1

5.1

28

28.4

Net Interest Expenses

-4.7

-6.8

-7.2

-2.8

19

21.2

Income (Loss) On Equity Invest.

8.9

17.4

20.1

20.7

17.7

15.8

Currency Exchange Gains (Loss)

—

—

—

—

4.6

1.5

1.4

4.1

-9.4

-11.4

Other Non Operating Income (Expenses)

—

—

—

—

—

—

—

—

—

—

-0.1

EBT, Excl. Unusual Items

304.8

434.7

787.2

789.3

737.8

636.2

Restructuring Charges

—

—

—

-3

-4.6

-2.2

-23.8

2

2.1

Gain (Loss) On Sale Of Investments

—

—

—

—

—

—

-2.5

-4.3

-3.5

-4.3

-4.3

Gain (Loss) On Sale Of Assets

—

—

—

—

—

-11.6

—

Asset Writedown

—

—

—

—

-2.7

-7.7

-8.4

-6.2

-9.6

-7.1

Legal Settlements

—

—

—

—

—

4.7

—

—

—

3.8

3.8

Other Unusual Items

-3.1

-1.2

-3.3

-55.2

-2.4

-3.6

EBT, Incl. Unusual Items

300.7

418.7

769

700.6

715.7

627.1

Income Tax Expense

59

72.5

107.2

114.7

122.3

102.2

Earnings From Continuing Operations

241.7

346.2

661.8

585.9

593.4

524.9

Net Income

241.7

346.2

661.8

585.9

593.4

524.9

Net Income to Common Incl Extra Items

241.7

346.2

661.8

585.9

593.4

524.9

Net Income to Common Excl. Extra Items

241.7

346.2

661.8

585.9

593.4

524.9

Total Shares Outstanding

74.1

74

74.2

74.1

73.5

72.6

Weighted Avg. Shares Outstanding

74

73.9

74.4

74.4

74.3

73.8

Weighted Avg. Shares Outstanding Dil

75.4

75.8

76.3

75.8

75.3

74.6

EPS

3.3

4.7

8.9

7.9

8

7.1

EPS Diluted

3.2

4.6

8.7

7.7

7.9

7

EBITDA

399.4

531.7

895.2

887.9

847.8

756.8

Effective Tax Rate

19.6%

17.3%

13.9%

16.4%

17.1%

16.3%